This study is not yet accepting patients
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Eli Lilly and Company
- ID
- NCT06876649
- Phase
- Phase 4 research study
- Study Type
- Interventional
- Participants
- Expecting 279 study participants
- Last Updated